Precision medicine has a blind spot: children with cancer

Cancer, once a terrifying black box, is slowly being opened up. Thanks to advances in technology and genomics, we know significantly more today about what drives cancer.

Precision medicine, the concept of giving the right treatment to the right patient at the right time, is flourishing in cancer treatment. But there is a blind spot: children are not benefiting enough from the progress we’re making.

We need a full-scale renaissance in pediatric drug development and care. And we need it now.

The full STAT article can be viewed at this link.